690 resultados para Helene Silverman
Resumo:
Resistance to virus infections in higher vertebrates is mediated in part through catalysis of RNA decay by the, interferon-regulated 2-5A system. A functional 2-5A system requires two enzymes, a 2-5A synthetase that produces 5'-phosphorylated, 2',5'-linked oligoadenylates (2-5A) in response to double-stranded RNA, and the 2-5A-dependent RNase L. We have coexpressed these human enzymes in transgenic tobacco plants by using a single plasmid containing the cDNAs for both human RNase L and a low molecular weight form of human 2-5A synthetase under control of different, constitutive promoters. Expression of the human cDNAs in the transgenic plants was demonstrated from Northern blots, by specific enzyme assays, and by immunodetection (for RNase L). Infection of leaves, detached or in planta, of the coexpressing transgenic plants by tobacco mosaic virus, alfalfa [correction of alfafa] mosaic virus, or tobacco etch virus resulted in necrotic lesions. In contrast, leaves expressing 2-5A synthetase or RNase L alone and leaves containing the plasmid vector alone produced typical systemic infections. While alfalfa mosaic virus produced lesions only in the inoculated leaves regardless of the concentration of virus in the inoculum, high, but not low, levels of tobacco etch virus inoculum resulted in escape of virus to uninoculated leaves. Nevertheless, there was a substantial reduction of tobacco etch virus yield as measured by ELISA assay in the coexpressing transgenic plants. These results indicate that expression of a mammalian 2-5A system in plants provides resistance to virus infections.
Resumo:
The three-dimensional structure of murine mitochondrial carbonic anhydrase V has been determined and refined at 2.45-A resolution (crystallographic R factor = 0.187). Significant structural differences unique to the active site of carbonic anhydrase V are responsible for differences in the mechanism of catalytic proton transfer as compared with other carbonic anhydrase isozymes. In the prototypical isozyme, carbonic anhydrase II, catalytic proton transfer occurs via the shuttle group His-64; carbonic anhydrase V has Tyr-64, which is not an efficient proton shuttle due in part to the bulky adjacent side chain of Phe-65. Based on analysis of the structure of carbonic anhydrase V, we speculate that Tyr-131 may participate in proton transfer due to its proximity to zinc-bound solvent, its solvent accessibility, and its electrostatic environment in the protein structure. Finally, the design of isozyme-specific inhibitors is discussed in view of the complex between carbonic anhydrase V and acetazolamide, a transition-state analogue. Such inhibitors may be physiologically important in the regulation of blood glucose levels.
Resumo:
The squamous cell carcinoma antigen (SCCA) is a member of the ovalbumin family of serine proteinase inhibitors (serpins). A neutral form of the protein is found in normal and some malignant squamous cells, whereas an acidic form is detected exclusively in tumor cells and in the circulation of patients with squamous cell tumors. In this report, we describe the cloning of the SCCA gene from normal genomic DNA. Surprisingly, two genes were found. They were tandemly arrayed and flanked by two other closely related serpins, plasminogen activator inhibitor type 2 (PAI2) and maspin at 18q21.3. The genomic structure of the two genes, SCCA1 and SCCA2, was highly conserved. The predicted amino acid sequences were 92% identical and suggested that the neutral form of the protein was encoded by SCCA1 and the acidic form was encoded by SCCA2. Further characterization of the region should determine whether the differential expression of the SCCA genes plays a causal role in development of more aggressive squamous cell carcinomas.
Resumo:
Combinatorial IgG Fab phage display libraries prepared from a systemic lupus erythematosus (SLE) donor and a healthy donor were affinity selected against human placental DNA. Human monoclonal antibody Fab fragments specific for DNA were isolated from both libraries, although Fabs of the highest affinity were isolated only from the lupus library. Generally, apparent affinities of the Fabs for human placental DNA, purified double-stranded DNA, and denatured DNA were approximately equivalent. Surface plasmon resonance indicated Fab binding constants for a double-stranded oligodeoxynucleotide of 0.2-1.3 x 10(8) M-1. The higher-affinity Fabs, as ranked by binding to human placental DNA or to the oligonucleotide probe, tested positive in the Crithidia luciliae assay commonly used in the diagnosis of SLE, and interestingly the genes encoding the heavy-chain variable regions of these antibodies displayed evidence of only minimal somatic hypermutation. The heavy chains of the SLE Fabs were characterized by a predominance of basic residues toward the N terminus of complementarity-determining region 3 (CDR3). The crucial role of heavy-chain CDR3 (HCDR3) in high-affinity DNA recognition was suggested by the creation of DNA binding in an unrelated antibody by HCDR3 transplantation from SLE antibodies. We propose that high-affinity DNA-binding antibodies can arise in SLE without extensive somatic hypermutation in the variable-region genes because of the expression of inappropriate HCDR3s.
Resumo:
O descarte de medicamentos envolve dois fluxos: o fluxo institucional, dos resíduos de fármacos, classificados como resíduos de serviços de saúde, utilizados na indústria e nas instituições de saúde; e o fluxo domiciliar, dos medicamentos vencidos/em desuso em poder da população. O descarte dos resíduos de medicamentos de origem domiciliar pode ser promovido pela logística reversa, onde este tipo de resíduo é devolvido ao setor empresarial para destinação final ambientalmente segura. O objetivo deste estudo foi identificar as estratégias mais viáveis para operacionalização da logística reversa de medicamentos. Trata-se de uma pesquisa exploratória, descritiva, com abordagem quantitativa. As estratégias foram avaliadas junto a atores da cadeia de valor farmacêutica: representantes do poder público, da indústria e distribuição farmacêutica, e consumidores/potenciais consumidores de medicamentos. Foram elaborados três questionários de avaliação de estratégias segundo seis critérios: mediação (articulação entre atores da cadeia produtiva farmacêutica por meio de políticas públicas); fiscalização (das ações); complexidade (de implantação e operacionalização); custos (de implantação e manutenção); adesão (potencialidade de ser inserida no cotidiano da população) e abrangência (potencialidade de alcançar a população). As estratégias foram hierarquizadas em ordem decrescente de viabilidade: rientações à população por profissionais de saúde, farmácias e internet, sinalização de informações nas embalagens e bulas de medicamentos, campanhas publicitárias e de educação ambiental e a disponibilização de postos de entrega voluntária. Os resultados poderão contribuir para a operacionalização de um sistema de logística reversa de medicamentos, considerando todos os atores envolvidos e buscando conciliar suas necessidades, possibilidades, limitações e interesses
Resumo:
An additional Heinrich ice-rafting event is identified between Heinrich events 5 and 6 in eight cores from the Labrador Sea and the northwest Atlantic Ocean. It is characterized by sediment rich in detrital carbonate (40% CaCO3) with high concentration of floating dropstones, high coarse-fraction (% > 150 µm) content, and has a sharp contact with the underlying but grades into the overlying hemipelagic sediment. It also shows lighter d18ONpl values, indicating freshening due to iceberg rafting and/or meltwater discharge. This event is correlated with Dansgaard-Oeschger event 14 and interpreted as an additional Heinrich event, H5a. The thickness of H5a in the Labrador Sea reaches up to 220 cm. This additional Heinrich event has also been reported in cores PS2644 and SO82-5 from the northern North Atlantic. With the recognition of H5a the temporal spacing between Heinrich events 1 to 6 becomes more uniform (~7 ka).
Resumo:
"PN-AAL-026"--Cover.
Resumo:
Front Row: swimming coach Jon Urbanchek, Rob Silverman, Mike Bayerl, Bill Hayes, Lee Michaud, Alec Campbell, Jan-Erick Olsen, Tim Petsche, Eric Kitchen, Martin Moran, Mike Barrowman, diving coach Dick Kimball
2nd Row: trainer Dave Tomchek, Eric Wise, D, Mott, Rick Reising, M. Smith, Alex Alvizuri, Zeb Esselstyn, Tato Ceresa, D. McNear, M. Curry, E. Gotting
3rd Row: David Parrish, Dan Dewhirst, Sean Gallagher, Steve Pancratz, Scott Van Appledorn, Dave Goch, Bill Kopas, G. Williams, Ron Howard, Rick Wilkening, A. DeLuca
Back Row: assistant coach Joe Parker, Scott Ryan, Bjoern Warland, Jarret Winter, Ron Melnyk, L. Aspenwall, Jeff Heydanek, Mats Nygren, Mike Creaser, graduate assistant Dan Kerska
Resumo:
Front Row: swimming coach Jon Urbanchek, Steve Duttenhofer, Steve Bigelow, Jim Hume, Noel Strauss, Greg Gooch, Brian Gunn, diving coach Dick Kimball
Middle Row: Gustavo Borges, Tom Hay, Rodney VanTassell, Matt Jaffe, Steve West, Tim Bower Chris Veber
Back Row: Bill Pettit, Dan Abruzzi, Thomas Blake, Kevin Glass, Bill Kopas, Kent Tschannen, trainer J. Petter. Eric Lesser
Not Pictured: Eric Bailey, Alex Bogaerts, Jayson Field, R. Genova, Drew Hansz, Jeff Jozwiak, John Kiani, Brad Lambert, Chad McCloud, asst. coach Mark Noetzel, Scott Pjesky, Abel Sanchez, Rob Silverman, Dan Valdes
Resumo:
Mode of access: Internet.